U.S. Oil and Gas Stock News

NasdaqCM:HNRG
NasdaqCM:HNRGRenewable Energy

A Closer Look at Hallador Energy (HNRG) Valuation After Strong Q3 Results and Expansion Plans

Hallador Energy (HNRG) delivered a standout third-quarter update, reporting big gains in both revenue and net income as energy demand spiked and coal and electric sales climbed. Favorable natural gas prices also contributed to the momentum. See our latest analysis for Hallador Energy. After its upbeat third-quarter earnings report and plans to expand capacity, Hallador Energy’s share price reflected renewed optimism, climbing over 8% in the past month and delivering a year-to-date share price...
NasdaqCM:SMTI
NasdaqCM:SMTIMedical Equipment

Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted?

Sanara MedTech Inc. has reported its third quarter 2025 earnings, revealing sales of US$26.33 million and a net loss of US$30.41 million, and announced the discontinuation of its Tissue Health Plus (THP) operations completed in November 2025 as part of a business realignment toward its core surgical segment. This shift not only repositions the company’s operational focus but also signals a response to deeper losses and the challenges faced by its digital health initiative. Now, we'll explore...
NasdaqCM:ABEO
NasdaqCM:ABEOBiotechs

Abeona Therapeutics (ABEO) Is Up 17.9% After ZEVASKYN Wins Permanent J-Code and Narrows Net Loss – Has The Bull Case Changed?

Abeona Therapeutics recently reported a third-quarter 2025 net loss of US$5.16 million, a significant improvement from US$30.27 million a year earlier, as its efforts to commercialize ZEVASKYN for RDEB patients advance alongside expanded treatment center access. A pivotal development includes the Centers for Medicare and Medicaid Services establishing a permanent J-code for ZEVASKYN, poised to support broader reimbursement and access from January 2026. With a 17.90% weekly and 18.47% daily...